Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Muir

Alan William Muir, Newhouse GB

Patent application numberDescriptionPublished
20100075938Use of Chemical Chelators as Reversal Agents for Drug-Induced Neuromuscular Block - The invention relates to the use of chemical chelators for the preparation of a medicament for the reversal of drug-induced neuromuscular block, to a kit for providing neuromuscular block and its reversal, and to cyclophane derivatives having the general formula A03-25-2010

Beinn V. O. Muir, London GB

Patent application numberDescriptionPublished
20120091008PH MEASUREMENT DEVICE - A fluid sampling element is adapted to receive a fluid sample, but also includes a pH sensor element adapted to measure pH of the fluid sample and a reference sensor element. The pH sensor element and the reference sensor element are adapted to generate a potential difference between each other based on the pH of the fluid sample. The pH of the fluid sample can be measured and the fluid sampling element can then be readily disposed of.04-19-2012

Derek Muir, Durham GB

Patent application numberDescriptionPublished
20090271941Upright Vacuum Cleaners - The present invention provides an upright vacuum cleaner (11-05-2009

Graeme Muir, Paisley GB

Patent application numberDescriptionPublished
20110315625DETECTION OF MICRO-ORGANISMS - Improved methods and devices for detecting microorganisms, such as yeast and bacteria in mixtures, are disclosed. Methods include passing a sample mixture thorough a filter device, which has been pretreated with detergent resuspending the filtrand from the filter membranes and detecting the presence of microorganisms in the filtrand.12-29-2011

James Campbell Muir, Macclesfield GB

Patent application numberDescriptionPublished
20090318415DIBENZOTHIAZEPINE DERIVATIVES AND USES THEREOF - 424 - Compounds the following formula:12-24-2009
20110160184Dibenzothiazepine Derivatives and Use Thereof - Compounds the following formula: wherein Z is as described in the specification, pharmaceutically acceptable salts thereof, compositions comprising the same, and methods of treating bipolar disorder, an anxiety disorder, a mood disorder or schizophrenia or other psychotic disorder with said compounds.06-30-2011

Jeffrey Muir, East Sussex GB

Laura Joy Muir, Alford GB

Patent application numberDescriptionPublished
20110273621Method of and apparatus for processing image data - The invention relates to a method (11-10-2011

Mark Muir, Edinburgh GB

Patent application numberDescriptionPublished
20110238504System And Method For Modifying Advertising Costs Based On The Visibility Of The Advertisement - The cost of advertisements, for example advertisements on the Internet, is based on the “visibility” of the advertisements. The visibility is determined by considering at least the following factors: the duration the advertisement is displayed, the geographical expanse the advertisement is displayed to, the broadness of the search terms associated with the advertisement and whether the advertisement is given premium placement.09-29-2011
20110238697System And Method For Two-Way Data Filtering - The addition of a two-way filter to computer networks, such as the Internet, uses both the criteria of the information producer (or product/service provider) and the criteria of the information consumer (or customer) to specifically target consumers with useful information or special offers on products or services they need during a specific time frame or time frames. Two-way filtering also permits customers or information consumers to quickly identify available products or services or information they are specifically interested in without requiring the customer to review hundreds, if not thousands, of sources, since the returned results have been heavily filtered. Two-way filtering is particularly important when it is used to match the service area the service provider is working in during a particular day (or a particular period of time) with customers in that service area that may need the services of the service provider.09-29-2011

Matthew Stewart Muir, Canterbury NZ

Patent application numberDescriptionPublished
20110021434Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof - The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity.01-27-2011

Neil Campbell Muir, Dansom Lane GB

Patent application numberDescriptionPublished
20080245890Device for Dispensing Volatile Compounds in a Gel to the Ambient Air - The invention relates to improvements in or relating to containers and in particular to an air freshening or purifying device comprising a primary container comprising an inner section and outer section each having a circumferential side wall. One of the sections has retaining means which defines at least one vapour release aperture and the other having a base. The inner section side wall is dimensioned so as to fit inside the outer section side wall, the two sections being interlockable to form the primary container. A refill container has a gel receiving surface having at least one recess for receiving a gel composition, and is located and firmly held within the primary container, the base being provided with means for attachment of the device to a surface.10-09-2008

Neil Campbell Muir, Hull GB

Patent application numberDescriptionPublished
20100216830Oral Composition Comprising A Cooling Agent - The present invention relates to a formulation comprising an endothermic cooling agent selected from the group consisting of xylitol, sorbitol, mannitol and erythritol having a heat of enthalpy between −10 cal/g and −100 cal/g, and one or more active agents wherein the endothermic agent is present in the formulation at an amount less than 10% w/w.08-26-2010

Victoria Justine Muir, Baywater NZ

Patent application numberDescriptionPublished
20100130410Neural regeneration peptides and methods for their use - Embodiments of this invention include novel peptides that can promote survival of neurons and other cell types. Other embodiments of this invention include the methods for the use of peptides to promote neuronal migration, neurite outgrowth, neuronal proliferation, neural differentiation, neuronal survival and/or trophoblast proliferation, trophoblast migration and trophoblase survival. NRP compounds may be administered directly to a subject or to a subject's cells by a variety of means including orally, intraperitoneally, intravascularly or indirectly via a replicable vehicle. NRP compounds can be formulated into pharmaceutically acceptable dosage forms for therapeutic use. Kits containing pre-determined doses of an NRP can be used to conveniently store, prepare and administer an NRP to a subject in need thereof.05-27-2010

Walter Muir, Peebles GB

Patent application numberDescriptionPublished
20090221670Method for diagnosis and treatment of a mental disease - The present invention relates to association of one or more polymorphisms located in the human NHP2L1, PACSIN2, SERHL, PIPPIN, BRD1, EP300, FAM19A5 and/or GPR24 genes to the occurrence of schizophrenia and/or bipolar disorder. The invention relates both to methods for diagnosing a predisposition to said diseases and for treating subjects having said diseases.09-03-2009